May 28, 2023 | Neurodiderot, Programs NeoPhen
The Sleep2Develop program investigates the role of sleep as a promotor of neurodevelopment and identifies the sleep determinants of childhood development. This is rephrased as Sleep(to)Develop? or Sleep(to)Develop! Our sleep research combines clinical and...
May 23, 2023 | NemoClinics, Neurodiderot
NemoClinics platform is hiring an engineer. Check out the opportunity here: U 1141 -Ingénieur-e en expérimentation et instrumentation biologiques- CDD 2023 Read more Job opportunity NemoClinics, NeurodiderotNemoClinics platform is hiring an engineer. Check out the...
Apr 17, 2023 | Neurodiderot, Programs NeoPhen
CCHS is a disease characterized by a congenital impairment of the central control of breathing, associated with dysfunctions of the autonomic nervous system (ANS) (Gallego, 2012). At birth, patients have severe and persistent hypoventilation during sleep and a...
Apr 14, 2023 | In press, NemoClinics, NeoPhen, Neurodiderot
In collaboration with Dr. Muriel Thoby-Brisson (Université de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d’Aquitaine, CNRS), and thanks to Fondation Air Liquide, Association Française du syndrome d’Ondine and start-up company ATMOSR, team...
Apr 14, 2023 | In press, NeoPhen, Neurodiderot
Pierre Alexis Geoffroy and team NeoPhen published a study in J Clin Psychiatry [1], showing that dream alterations and their progression can be readily assessed and may help to better identify prodromal signs of suicidal behaviors. A study highlighted in Inserm...
Jun 27, 2022 | NemoClinics, NeoPhen, Neurodiderot, Projetcs
Team NeoPhen, in collaboration with team NeuroDev (Dr. Andrée Delahaye), receive support from the CCHS Foundation in 2022 to study the genetic dysregulations that could be associated with Congenital Central Hypoventilation Syndrome (CCHS). Members of the NeoPhen and...
